Diagnostics News and Research

RSS

Leptospirosis: The newest public health threat in Africa

The newest public health threat in Africa, scientists have found, is coming from a previously unknown source: the banded mongoose.

15 May 2013

Virginia Tech researchers identify leptospirosis as a major health threat in Botswana

The newest public health threat in developing countries may not be a cinematic-quality emerging disease but actually a disease from animals that was identified more than 100 years ago.

15 May 2013

LDL cholesterol blood level declines found to have abruptly ended in 2008

Decades of declines in LDL cholesterol blood levels, a key marker of death risk from heart disease, abruptly ended in 2008, and may have stalled since, according to a multi-year, national study published in PLOS ONE.

From Quest Diagnostics 14 May 2013

Researchers discover connection between CB1 receptors and PTSD

In a first-of-its-kind effort to illuminate the biochemical impact of trauma, researchers at NYU Langone Medical Center have discovered a connection between the quantity of cannabinoid receptors in the human brain, known as CB1 receptors, and post-traumatic stress disorder, the chronic, disabling condition that can plague trauma victims with flashbacks, nightmares and emotional instability.

14 May 2013

New study provides clear picture of the impact and causes of diarrheal diseases

A new international study published today in The Lancet provides the clearest picture yet of the impact and most common causes of diarrheal diseases, the second leading killer of young children globally, after pneumonia.

14 May 2013

New diagnostic test could help health officials monitor, prevent spread of H7N9 virus

Breaking research appearing online today in Clinical Chemistry, the journal of AACC, demonstrates that a recently developed diagnostic test can detect the new strain of influenza (H7N9) currently causing an outbreak in China.

13 May 2013

New British technologies are transforming healthcare and saving lives

Innovative projects including: smart-phone test and tracking systems for infectious diseases; fibre optic probes that can monitor people's condition in intensive care; and in-home sensors that can relay patient information to doctors immediately, have benefitted from a -32 million investment.

10 May 2013

Children born with CDG don't contain mutation in every cell type, say Sanford-Burnham researchers

Children born with rare, inherited conditions known as Congenital Disorders of Glycosylation, or CDG, have mutations in one of the many enzymes the body uses to decorate its proteins and cells with sugars.

10 May 2013

Abbott receives CE Mark for ARCHITECT HbA1c test

Abbott today announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c test, which may aid physicians in diagnosing and monitoring diabetes as well as identifying patients at risk for developing diabetes.

9 May 2013

UA researchers discover genetic mutations that cause severe epilepsies in children

Researchers at the University of Arizona have successfully determined the genetic mutations causing severe epilepsies in seven out of 10 children for whom the cause of the disorder could not be determined clinically or by conventional genetic testing.

9 May 2013

Exosome Diagnostics' urine exosome technology accurately predicts outcome of prostate biopsy

Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic products for use in personalized medicine research and clinical diagnostics, today announced the presentation of data at the American Urological Association Annual Meeting in San Diego demonstrating the performance of urine exosome technology in accurately predicting the outcome of a prostate biopsy.

9 May 2013

Good Start Genetics gets $28M loan from Capital Royalty

Good Start Genetics, Inc., an innovative molecular diagnostics company that has developed the new gold standard in carrier screening, today announced that it has closed a non-dilutive loan facility for up to $28 million of capital from Capital Royalty L.P.

8 May 2013

BIOTRONIK receives FDA approval for ICD/CRT-D series

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced that the Food and Drug Administration granted approval for its Ilesto 7 implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillator series.

8 May 2013

Public-private partnerships can help advance global health goals

"Three people die every minute from tuberculosis -- a treatable and largely preventable disease. Resistant forms continue to thrive, and increased travel makes the global threat very real. We face a public health emergency," Vince Forlenza, chair, CEO, and president of the medical technology firm Becton, Dickinson and Company, writes in the Harvard Business Review Blog Network.

3 May 2013

New approach could democratize viral surveillance, says UCSF scientist

The tick-borne Lone Star virus has been conclusively identified as part of a family of other tick-borne viruses called bunyaviruses, which often cause fever, respiratory problems and bleeding, according to new research led by scientists at UC San Francisco.

3 May 2013

Cancer Genetics introduces proprietary urogenital cancer array for diagnosing kidney cancer

Cancer Genetics, Inc., a leader in oncology-focused personalized medicine, has launched a proprietary urogenital cancer array, UroGenRA, intended for kidney cancer diagnosis and subtyping in its own laboratory.

3 May 2013

Prosigna Breast Cancer Prognostic Gene Signature Assay predicts ROR in women with early-stage breast cancer

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced results from two studies that are featured in oral presentations this week at IMPAKT Breast Cancer Conference.

2 May 2013

EventusDx receives CE mark designation for Octava Pink breast cancer test

Eventus Diagnostics, Inc. today announced that it has received CE mark designation for its Octava Pink™ breast cancer test intended for confirmatory use in women who have received negative mammography results.

2 May 2013

HCV screening of prison inmate drug users: an interview with Dr. Arthur Kim, Massachusetts General Hospital and Harvard Medical School

Prisoners overall have a very high rate of past or present injection drug use, which is a major risk factor for HCV infection due to repeated exposures to needles.

1 May 2013

Neurons in the nose could be the key to early diagnosis of schizophrenia, says researcher

A debilitating mental illness, schizophrenia can be difficult to diagnose. Because physiological evidence confirming the disease can only be gathered from the brain during an autopsy, mental health professionals have had to rely on a battery of psychological evaluations to diagnose their patients.

30 Apr 2013

Diagnostics News and Research

Leptospirosis: The newest public health threat in Africa

Virginia Tech researchers identify leptospirosis as a major health threat in Botswana

LDL cholesterol blood level declines found to have abruptly ended in 2008

Researchers discover connection between CB1 receptors and PTSD

New study provides clear picture of the impact and causes of diarrheal diseases

New diagnostic test could help health officials monitor, prevent spread of H7N9 virus

New British technologies are transforming healthcare and saving lives

Children born with CDG don't contain mutation in every cell type, say Sanford-Burnham researchers

Abbott receives CE Mark for ARCHITECT HbA1c test

UA researchers discover genetic mutations that cause severe epilepsies in children

Exosome Diagnostics' urine exosome technology accurately predicts outcome of prostate biopsy

Good Start Genetics gets $28M loan from Capital Royalty

BIOTRONIK receives FDA approval for ICD/CRT-D series

Public-private partnerships can help advance global health goals

New approach could democratize viral surveillance, says UCSF scientist

Cancer Genetics introduces proprietary urogenital cancer array for diagnosing kidney cancer

Prosigna Breast Cancer Prognostic Gene Signature Assay predicts ROR in women with early-stage breast cancer

EventusDx receives CE mark designation for Octava Pink breast cancer test

HCV screening of prison inmate drug users: an interview with Dr. Arthur Kim, Massachusetts General Hospital and Harvard Medical School

Neurons in the nose could be the key to early diagnosis of schizophrenia, says researcher

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News